MRI Evaluation of Iron Overload in the Heart, Liver and Pancreas in Patients Receiving Multiple Blood Transfusions.
Sponsored by Sheba Medical Center
About this trial
Last updated 15 years ago
Study ID
SHEBA-07-4859-OG-CTIL
Status
Completed
Type
Observational
Placebo
No
Accepting
18 to 35 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 15 years ago
What is this trial about?
Sickle cell anemia and Sickle cell β thalassemia patients require multiple transfusions
in order to avoid chronic anemia sequel. This regimen entails intrinsic deleterious
effects, the majority of which are related to iron deposition in the reticuloendothelial
system. Thus, iron is deposited in hepatic, myocardial and endocrine glands tissues.
Tools available for iron load evaluation include serum ferrtin levels, liver biopsy and
echocardiography, all are non specific.
The purpose of this work is to compare iron overload in the liver, heart and pancreas in
Sickle cell anemia and Sickle cell β thalassemia patients using T2* MRI sequences.
What are the participation requirements?
Inclusion Criteria
- clinical diagnosis of Sickle cell anemia or Sickle cell β thalassemia having received multiple blood transfusions.
Exclusion Criteria
- contraindication to MRI